![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Endometrial cancers are the most common gynecological malignancies in developed countries. Surgery is the main treatment modality but radiotherapy and, increasingly, chemotherapy are used to treat women with advanced disease and those at high risk of recurrence. Although the treatment of endometrial cancer is becoming increasingly evidence based, there remains a lack of consensus in several aspects of management. These include issues related to the type and extent of surgery and the role of adjuvant treatments as well as more conservative treatment options for younger women. This article discusses these unresolved issues, the current evidence in these areas, and highlights where current research is attempting to answer some of the outstanding questions.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.